Read the article 'Et Tu Nilotinib?: Understanding Headlines about an Anti-Cancer Drug for PD' which appeared in the recent Parkinson's Disease Foundation (PDF) blog,  by Dr. James Beck, Ph.D., Vice President, Scientific Affairs, PDF. (Dr Beck is pictured above left at one of CPT's Linked Clinical Trials meetings with Tom Isaacs, co-founder CPT and Steve DeWitte, Advocate, PDF)